Join Today

PMC members shape and advance the future of personalized medicine.
» Sign Up Today


Stakeholders Endorse PMI as Timely and Promising

In the latest effort to help Americans make sense of President Obama’s Precision Medicine Initiative (PMI), government officials and other leaders contributed articles to an insert on the topic that was published digitally and distributed in print with 250,000 copies of USA Today on June 26, 2015. Collectively, the articles make the case that the PMI is a timely and promising effort to move medicine toward a new paradigm.
» Education & Advocacy

Genetic Support Could Double Drug Development Success Rate
A new study published in Nature Genetics demonstrates that pursuing drug targets supported by genetic evidence could double the clinical development success rate.
» Nature Genetics

Accusations of Unethical Research Challenge the Field
A legal battle over the ethics of a genetic testing study is making demonstration of the field's commitment to unbiased research even more imperative.
» The New York Times

Member News

Foundation Medicine CEO: Roche Deal Poises Company for Success

Addressing concerns that Roche's becoming the new majority shareholder of Foundation Medicine might hold the company captive to Roche's drug development needs, Foundation CEO Michael Pellini described the deal as "an accelerator of Foundation Medicine as an independent company" in a recent interview with IN VIVO.

Study Demonstrates Afatinib Improves Survival
Recently published study results demonstrate significantly improved overall survival rates for patients with squamous cell carcinoma of the lung taking afatinib, as compared to those taking erlotinib.
» Boehringer Ingelheim

Health Policy Expert Amy Jensen Cunniffe Joins WECY
Washington Council Ernst & Young (WCEY) recently announced that former White House official and health policy expert Amy Jensen Cunniffe has joined its legislative group as a principal.
» Ernst & Young